![\"A](\"https:\/\/www.europesays.com\/uk\/wp-content\/uploads\/2025\/05\/0_The-Stablepharma-tetanus-diphtheria-vaccine-SPVX02-is-completely-stable-at-room-temperature-and-th.webp\")
The vaccine used in the trial does not require a fridge and the firm behind it says up to 60 other vaccines may benefit from the advance in technology(Image: PA Wire\/PA Images)<\/p>\nThe Stablepharma tetanus-diphtheria vaccine (SPVX02) does not need to be stored in a fridge and the firm behind it says up to 60 other vaccines may benefit from the technologyThe vaccine used in the trial does not require a fridge and the firm behind it says up to 60 other vaccines may benefit from the advance in technology(Image: PA Wire\/PA Images)<\/p>\n
The UK is paving the way for medical<\/a> advancement with the launch of a first-of-its-kind clinical trial of a vaccine that doesn’t require refrigeration. This could potentially revolutionise vaccine distribution.<\/p>\n This groundbreaking initiative tests the tetanus-diphtheria vaccine (SPVX02) developed by Stablepharma, which stays perfectly stable at ambient temperatures. The company is optimistic about leveraging this technology<\/a> to help up to 60 other vaccines avoid the fridge.<\/p>\n Currently, the vaccine’s human trial is underway at the National Institute for Health and Care Research (NIHR) Southampton clinical research facility situated in University Hospital Southampton<\/a>.<\/p>\n One of the major hurdles in immunization efforts, particularly in certain regions around the world<\/a>, is maintaining the “cold chain” \u2013 the vital cool conditions from production until administration of the vaccine.<\/p>\n READ MORE: LBC caller asks Kemi Badenoch brutal question on live radio as she says ‘I’m sorry’<\/a>READ MORE: ‘Red flag’ symptom that could be a sign of stroke or meningitis<\/a><\/p>\n According to the World Health Organisation (WHO), nearly half of the vaccines globally are discarded each year, with improper temperature control and cold-chain logistical issues largely to blame<\/p>\n .Stablepharma, a UK-based biotech firm, has demonstrated that it can transform existing, approved vaccines into non-refrigerated versions with the potential for long-term room temperature storage.<\/p>\n Health and Social Care Secretary Wes Streeting applauded the development: “For years, vaccines have been held back by the need to be stored in a fridge \u2013 causing endless amounts of wastage and making it difficult to deliver them to remote communities.”<\/p>\n He heralded what may be a turning point brought by this cutting-edge research: “But thanks to this Government’s vision and our investment through the National Institute for Health and Care Research, all that could be about to change.”<\/p>\n \u201cWe are leading the charge by pushing through the world\u2019s first trial for fridge-free vaccines.<\/p>\n “This could be a real game changer and lifesaver globally \u2013 as it unlocks new ways for poorer nations to deliver vaccines to their patients, where they’re often needed the most.”<\/p>\n The health secretary added: “Groundbreaking science is amongst the things that Britain does best, and this innovation reaffirms our position as a world leader in vaccine development and research, boosting growth and economic security \u2013 the cornerstone of our Plan for Change.”<\/p>\n Professor Saul Faust from the University of Southampton and Dr Karen O’Hanlon, chief development officer at Stablepharma, are guiding the pivotal clinical trial.<\/p>\n Prof Faust said: “It is fantastic to see cutting-edge UK science reach the milestone of a first clinical trial and to be able to give the opportunity for people living on the south coast to take part.<\/p>\n “This research will be an important step toward exploring whether this innovation could eradicate vaccine wastage and move away from the need for the cold-chain.”<\/p>\n Expectations are high that the study will wrap up by summer, with results awaiting release by year-end. With ambitious targets set by Stablepharma, the innovative vaccine could be deployed worldwide by 2027.<\/p>\n","protected":false},"excerpt":{"rendered":"The Stablepharma tetanus-diphtheria vaccine (SPVX02) does not need to be stored in a fridge and the firm behind…\n","protected":false},"author":2,"featured_media":75944,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4316],"tags":[37454,105,4348,2207,3912,16,15,37453,3595,1823],"class_list":{"0":"post-75943","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-coronavirus-vaccine","9":"tag-health","10":"tag-healthcare","11":"tag-hospitals","12":"tag-medicine","13":"tag-uk","14":"tag-united-kingdom","15":"tag-university-of-southampton","16":"tag-wes-streeting","17":"tag-world-health-organisation"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/114454172091642312","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/75943","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=75943"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/75943\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/75944"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=75943"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=75943"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=75943"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}![\"Vials](\"https:\/\/www.europesays.com\/uk\/wp-content\/uploads\/2025\/05\/1_Coronavirus-Fri-Apr-9-2021.jpg\")
Many vaccines have to be stored and transported at low temperatures for them to be safe to use(Image: PA)<\/p>\n